Skip Navigation


European Heart Journal Advance Access originally published online on June 6, 2006
European Heart Journal 2006 27(13):1521-1522; doi:10.1093/eurheartj/ehl075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/13/1521    most recent
ehl075v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tendera, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tendera, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

How much does Europe invest in the treatment of cardiovascular diseases?

Michal Tendera*

3rd Division of Cardiology, Silesian School of Medicine, Ziolowa Street 47, 40-635 Katowice, Poland

* Corresponding author. E-mail address: mtendera@kardio3.katowice.pl

This editorial refers to ‘Economic burden of cardiovascular diseases in the enlarged European Union’{dagger} by J. Leal et al., on page 1610

The first 10% of the full text of this article appears below.

Cardiovascular diseases (CVD) remain the most important cause of premature death and morbidity in the European Union (EU). Although standardized mortality has steadily decreased over the last 15–20 years in most European countries, the absolute number of cardiovascular deaths remains relatively steady.1 Patients live longer, and experience more non-fatal events. With this epidemiological shift, the overall burden of CVD is likely to increase rather than decrease in the future.

Economical consequences of CVD are therefore enormous, and are still rising as the population ages. For example, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Economic burden of cardiovascular diseases in the enlarged European Union
José Leal, Ramón Luengo-Fernández, Alastair Gray, Sophie Petersen, and Mike Rayner
EHJ 2006 27: 1610-1619. [Abstract] [Full Text]